Literature DB >> 7648650

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction.

P T Kovanen1, M Kaartinen, T Paavonen.   

Abstract

BACKGROUND: Erosion and rupture of coronary atheromas are the events preceding the vast majority of acute coronary syndromes. The shoulder regions of atheromas, the sites at which erosion or rupture is most likely to occur, are the sites at which mast cells accumulate. These cells are filled with neutral proteases capable of triggering extracellular matrix degradation via activation of matrix metalloproteinases. To obtain more direct evidence for the participation of mast cells in the acute coronary syndromes, we quantified the numbers of mast cells at eroded or ruptured sites of coronary atheromas in patients who died of myocardial infarction. METHODS AND
RESULTS: In specimens of coronary arteries from 20 patients who had died of acute myocardial infarction, the site of atheromatous erosion or rupture was identified. The specimens were stained with monoclonal antibodies against the two major proteases of mast cells, tryptase and chymase, and against macrophages, T lymphocytes, and smooth muscle cells. At the immediate site of erosion or rupture, mast cells amounted to 6% of all nucleated cells, in the adjacent atheromatous area to 1%, and in the unaffected intimal area to 0.1%. The proportions of these mast cells that were activated, ie, had been stimulated to degranulate and release some of their tryptase and chymase contents, were 86% at the site of erosion or rupture, 63% in the adjacent atheromatous area, and 27% in the unaffected intima. At the site of erosion or rupture, the numbers of macrophages and T lymphocytes were also increased, but the number of smooth muscle cells was decreased.
CONCLUSIONS: The accumulation of activated mast cells (200-fold more than in the unaffected coronary intima) at the site of atheromatous erosion or rupture suggests that in thrombotic coronary occlusion the role played by mast cells is significant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7648650     DOI: 10.1161/01.cir.92.5.1084

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  94 in total

1.  Coronary artery disease, inflammation and the ghost of John Hunter.

Authors:  Ernest L Fallen
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

Review 2.  Kounis syndrome (allergic acute coronary syndrome): different views in allergologic and cardiologic literature.

Authors:  Filippo Fassio; Fabio Almerigogna
Journal:  Intern Emerg Med       Date:  2012-01-22       Impact factor: 3.397

3.  A new cardiac MASTer switch for the renin-angiotensin system.

Authors:  Thu H Le; Thomas M Coffman
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 4.  Mast cells in atherogenesis: actions and reactions.

Authors:  Petri T Kovanen
Journal:  Curr Atheroscler Rep       Date:  2009-05       Impact factor: 5.113

5.  Kounis syndrome - an atopic monster for the heart.

Authors:  Venkataramanan Gangadharan; Samit Bhatheja; Kais Al Balbissi
Journal:  Cardiovasc Diagn Ther       Date:  2013-03

6.  Protease activated receptors in cardiovascular function and disease.

Authors:  Junor A Barnes; Shamjeet Singh; Aldrin V Gomes
Journal:  Mol Cell Biochem       Date:  2004-08       Impact factor: 3.396

7.  Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome.

Authors:  Nobuo Sakamoto; Yasuto Hoshino; Tomofumi Misaka; Hiroyuki Mizukami; Satoshi Suzuki; Koichi Sugimoto; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Hitoshi Suzuki; Shu-ichi Saitoh; Yasuchika Takeishi
Journal:  Heart Vessels       Date:  2013-03-27       Impact factor: 2.037

8.  Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.

Authors:  Saman Rasoul; Oscar A Carretero; Hongmei Peng; Maria A Cavasin; Jialong Zhuo; Alicia Sanchez-Mendoza; David R Brigstock; Nour-Eddine Rhaleb
Journal:  J Hypertens       Date:  2004-03       Impact factor: 4.844

Review 9.  Innate and adaptive immunity in atherosclerosis.

Authors:  René R S Packard; Andrew H Lichtman; Peter Libby
Journal:  Semin Immunopathol       Date:  2009-05-16       Impact factor: 9.623

10.  Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice.

Authors:  Maurice Nachtigal; Abdul Ghaffar; Eugene P Mayer
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.